• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll 样受体信号转导的缺陷负调控导致骨髓增殖性肿瘤中 TNF-α 过多。

Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm.

机构信息

Department of Biological Chemistry, and.

Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA.

出版信息

Blood Adv. 2019 Jan 22;3(2):122-131. doi: 10.1182/bloodadvances.2018026450.

DOI:10.1182/bloodadvances.2018026450
PMID:30647074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6341195/
Abstract

Patients with myeloproliferative neoplasms (MPN) have high levels of inflammatory cytokines, some of which drive many of the debilitating constitutional symptoms associated with the disease and may also promote expansion of the neoplastic clone. We report here that monocytes from patients with MPN have defective negative regulation of Toll-like receptor (TLR) signaling that leads to unrestrained production of the inflammatory cytokine tumor necrosis factor α (TNF-α) after TLR activation. Specifically, monocytes of patients with MPN are insensitive to the anti-inflammatory cytokine interleukin 10 (IL-10) that negatively regulates TLR-induced TNF-α production. This inability to respond to IL-10 is a not a direct consequence of , as the phenotype of persistent TNF-α production is a feature of and wild-type monocytes alike from -positive patients. Moreover, persistent TNF-α production was also discovered in the unaffected identical twin of a patient with MPN, suggesting it could be an intrinsic feature of those predisposed to acquire MPN. This work implicates sustained TLR signaling as not only a contributor to the chronic inflammatory state of MPN patients but also a potential predisposition to acquire MPN.

摘要

骨髓增殖性肿瘤(MPN)患者的炎症细胞因子水平较高,其中一些细胞因子可导致与疾病相关的许多使人衰弱的全身症状,并可能促进肿瘤克隆的扩张。我们在此报告,MPN 患者的单核细胞存在 Toll 样受体(TLR)信号的负调控缺陷,导致 TLR 激活后炎症细胞因子肿瘤坏死因子 α(TNF-α)的不受控制产生。具体而言,MPN 患者的单核细胞对负向调节 TLR 诱导的 TNF-α产生的抗炎细胞因子白细胞介素 10(IL-10)不敏感。这种对 IL-10 无反应的能力不是由于 所致,因为持续性 TNF-α产生的表型是 和阳性患者的野生型单核细胞的共同特征。此外,还在一名 MPN 患者的未受影响的同卵双胞胎中发现了持续性 TNF-α产生,这表明它可能是那些易患 MPN 的内在特征。这项工作表明,持续的 TLR 信号不仅是 MPN 患者慢性炎症状态的一个促成因素,也是获得 MPN 的潜在倾向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/6341195/9e5f554354ee/advances026450absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/6341195/9e5f554354ee/advances026450absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/6341195/9e5f554354ee/advances026450absf1.jpg

相似文献

1
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm.Toll 样受体信号转导的缺陷负调控导致骨髓增殖性肿瘤中 TNF-α 过多。
Blood Adv. 2019 Jan 22;3(2):122-131. doi: 10.1182/bloodadvances.2018026450.
2
JAK2-V617F is a negative regulation factor of SHIP1 protein and thus influences the AKT signaling pathway in patients with Myeloproliferative neoplasm (MPN).JAK2-V617F 是 SHIP1 蛋白的负调控因子,从而影响骨髓增殖性肿瘤(MPN)患者的 AKT 信号通路。
Int J Biochem Cell Biol. 2022 Aug;149:106229. doi: 10.1016/j.biocel.2022.106229. Epub 2022 May 21.
3
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.TNFα 促进骨髓增殖性肿瘤中 JAK2V617F 阳性细胞的克隆扩增。
Blood. 2011 Dec 8;118(24):6392-8. doi: 10.1182/blood-2011-04-348144. Epub 2011 Aug 22.
4
Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.JAK2(V617F)骨髓增殖性肿瘤患者中 PD-L1 的异位表达是通过 STAT3 和 STAT5 的激活增加介导的。
Hum Cell. 2020 Oct;33(4):1099-1111. doi: 10.1007/s13577-020-00370-6. Epub 2020 Jul 14.
5
Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.促红细胞生成素受体中的三个酪氨酸残基对Janus激酶2 V617F突变体诱导的肿瘤发生至关重要。
J Biol Chem. 2017 Feb 3;292(5):1826-1846. doi: 10.1074/jbc.M116.749465. Epub 2016 Dec 20.
6
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms.白细胞介素-33信号传导参与骨髓增殖性肿瘤的发病机制。
J Clin Invest. 2015 Jul 1;125(7):2579-91. doi: 10.1172/JCI77347. Epub 2015 May 26.
7
Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation .巨核细胞中 JAK/STAT 信号的激活维持骨髓增殖。
Clin Cancer Res. 2019 Oct 1;25(19):5901-5912. doi: 10.1158/1078-0432.CCR-18-4089. Epub 2019 Jun 19.
8
Oncogenic JAK2 causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms.致癌性 JAK2 导致 PD-L1 表达,介导骨髓增殖性肿瘤中的免疫逃逸。
Sci Transl Med. 2018 Feb 21;10(429). doi: 10.1126/scitranslmed.aam7729.
9
Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.衔接蛋白 Lnk 的表达水平和差异 JAK2-V617F 结合调节骨髓增殖性肿瘤中的 JAK2 介导的信号。
Blood. 2010 Dec 23;116(26):5961-71. doi: 10.1182/blood-2009-12-256768. Epub 2010 Sep 24.
10
Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients.巴西患者中TNF基因多态性与JAK2(V617F)骨髓增殖性肿瘤的关联。
Blood Cells Mol Dis. 2016 Mar;57:54-7. doi: 10.1016/j.bcmd.2015.12.005. Epub 2015 Dec 10.

引用本文的文献

1
Monocyte Involvement in the Pathogenesis of Myeloproliferative Neoplasms.单核细胞在骨髓增殖性肿瘤发病机制中的作用
Int J Mol Sci. 2025 Jul 3;26(13):6422. doi: 10.3390/ijms26136422.
2
TNF-α impairs platelet function by inhibiting autophagy and disrupting metabolism via syntaxin 17 downregulation.肿瘤坏死因子-α通过抑制自噬和经由 syntaxin 17 下调破坏代谢来损害血小板功能。
J Clin Invest. 2025 Jun 10;135(15). doi: 10.1172/JCI186065. eCollection 2025 Aug 1.
3
Potential application of the bulk RNA sequencing in routine MPN clinics.批量RNA测序在骨髓增殖性肿瘤常规临床中的潜在应用。

本文引用的文献

1
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study.骨髓增殖性肿瘤患者的动脉和静脉血栓形成风险:一项基于人群的队列研究。
Ann Intern Med. 2018 Mar 6;168(5):317-325. doi: 10.7326/M17-0028. Epub 2018 Jan 16.
2
Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness.病原体诱导造血干细胞中 TLR4-TRIF 先天免疫信号促进增殖,但降低竞争适应性。
Cell Stem Cell. 2017 Aug 3;21(2):225-240.e5. doi: 10.1016/j.stem.2017.06.013. Epub 2017 Jul 20.
3
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
BMC Cancer. 2025 Apr 22;25(1):746. doi: 10.1186/s12885-025-13947-x.
4
Transcriptomic profiling identifies ferroptosis and NF-κB signaling involved in α-dimorphecolic acid regulation of microglial inflammation.转录组分析确定铁死亡和NF-κB信号传导参与α-二甲基苯并二氢吡喃酸对小胶质细胞炎症的调节。
J Transl Med. 2025 Mar 4;23(1):260. doi: 10.1186/s12967-025-06296-7.
5
JAK Inhibitors for Myelofibrosis: Strengths and Limitations.JAK 抑制剂治疗骨髓纤维化:优势与局限。
Curr Hematol Malig Rep. 2024 Dec;19(6):264-275. doi: 10.1007/s11899-024-00744-9. Epub 2024 Oct 14.
6
Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.高浓度的损伤相关分子模式 HMGB1 和 S100A8/A9 与 Toll 样受体触发的单核细胞激活相关,与骨髓纤维化患者的炎症有关。
Front Immunol. 2024 Sep 25;15:1365015. doi: 10.3389/fimmu.2024.1365015. eCollection 2024.
7
Immune-dysregulation harnessing in myeloid neoplasms.髓系肿瘤中的免疫失调调控。
Cancer Med. 2024 Sep;13(17):e70152. doi: 10.1002/cam4.70152.
8
TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic model.肿瘤坏死因子-α是鉴别骨髓增殖性肿瘤和特发性红细胞增多症/血小板增多症的预测标志物:一种非侵入性诊断模型的建立与验证
Front Oncol. 2024 Mar 22;14:1369346. doi: 10.3389/fonc.2024.1369346. eCollection 2024.
9
The impact of gut microbial signals on hematopoietic stem cells and the bone marrow microenvironment.肠道微生物信号对造血干细胞和骨髓微环境的影响。
Front Immunol. 2024 Feb 13;15:1338178. doi: 10.3389/fimmu.2024.1338178. eCollection 2024.
10
Inherited polygenic effects on common hematological traits influence clonal selection on JAK2 and the development of myeloproliferative neoplasms.遗传多基因效应对常见血液学特征的影响影响 JAK2 的克隆选择和骨髓增殖性肿瘤的发展。
Nat Genet. 2024 Feb;56(2):273-280. doi: 10.1038/s41588-023-01638-x. Epub 2024 Jan 17.
生殖系变异易导致JAK2 V617F克隆性造血和骨髓增殖性肿瘤。
Blood. 2016 Aug 25;128(8):1121-8. doi: 10.1182/blood-2015-06-652941. Epub 2016 Jun 30.
4
Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms.费城染色体阴性慢性骨髓增殖性肿瘤中的既往心血管疾病和自身免疫
Leuk Res. 2016 Feb;41:27-35. doi: 10.1016/j.leukres.2015.11.017. Epub 2015 Dec 2.
5
MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.骨髓增殖性肿瘤作为炎症性疾病:证据、后果及展望
Mediators Inflamm. 2015;2015:102476. doi: 10.1155/2015/102476. Epub 2015 Oct 28.
6
Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development.炎症对骨髓增殖性肿瘤症状发展的影响。
Mediators Inflamm. 2015;2015:284706. doi: 10.1155/2015/284706. Epub 2015 Oct 11.
7
JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.恶性和非恶性细胞中的JAK-STAT信号通路激活有助于骨髓增殖性肿瘤的发病机制和治疗反应。
Cancer Discov. 2015 Mar;5(3):316-31. doi: 10.1158/2159-8290.CD-14-0736. Epub 2015 Jan 8.
8
Chronic TLR signaling impairs the long-term repopulating potential of hematopoietic stem cells of wild type but not Id1 deficient mice.慢性 TLR 信号转导会损害野生型造血干细胞的长期重编程能力,但不会损害 Id1 缺陷型小鼠的造血干细胞的长期重编程能力。
PLoS One. 2013;8(2):e55552. doi: 10.1371/journal.pone.0055552. Epub 2013 Feb 1.
9
Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis.真性红细胞增多症患者血浆细胞因子:表型相关性、预后相关性及与骨髓纤维化的比较。
Am J Hematol. 2012 Nov;87(11):1003-5. doi: 10.1002/ajh.23295. Epub 2012 Sep 11.
10
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.芦可替尼治疗骨髓纤维化的双盲、安慰剂对照试验。
N Engl J Med. 2012 Mar 1;366(9):799-807. doi: 10.1056/NEJMoa1110557.